Fidelity Disruptive Medicine ETF Rating $30.25 +0.13 (+0.43%) As of 01:51 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsTrendsBuy This Stock Fidelity Disruptive Medicine ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FMED Aggregate RatingModerate Buy 2.72Holdings in FMED have an aggregate rating of Moderate Buy based on 433 analyst ratings issued in the past year covering 22 companies (55.2% of the portfolio).FMED Aggregate Price Target$30.25High Prediction$30.25Average Prediction$30.25Low Prediction$30.25Holdings in FMED have an aggregate price target of $30.25 and a range of $30.25 to $30.25 covering 22 companies (55.2% of the portfolio).FMED Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Fidelity Disruptive Medicine ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 22 FMED Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.26%TXG10x Genomics$56.59-2.7%1.7203 of 5 stars2.25$38.31 -32.3%16Analyst ForecastInsider Trade3.90%TMOThermo Fisher Scientific$592.57-0.6%4.64 of 5 stars2.79$619.41 4.5%24Insider Trade3.83%DHRDanaher$203.48-0.2%4.399 of 5 stars2.84$228.91 12.5%253.14%LFSTLifeStance Health Group$12.63+3.3%2.8478 of 5 stars2.73$12.13 -4.0%11Analyst UpgradeInsider Trade3.03%RVMDRevolution Medicines$202.92+0.5%2.4215 of 5 stars2.91$161.79 -20.3%22Analyst Forecast2.87%COGTCogent Biosciences$37.73+1.1%2.3992 of 5 stars2.85$49.10 30.1%13Positive NewsEarnings ReportAnalyst Forecast2.81%ARGXargenex$849.02-0.9%4.7898 of 5 stars2.92$1,056.89 24.5%242.65%ILMNIllumina$192.02-0.3%3.235 of 5 stars2.47$188.40 -1.9%17Positive News2.39%NTRANatera$310.53-0.1%2.6901 of 5 stars2.82$319.38 2.9%22Analyst Forecast2.24%ISRGIntuitive Surgical$397.38-1.0%4.6431 of 5 stars2.68$508.68 28.0%31Positive NewsAnalyst UpgradeInsider TradeGap Up2.20%KYMRKymera Therapeutics$116.61+1.9%1.0472 of 5 stars2.83$125.65 7.8%232.20%ALNYAlnylam Pharmaceuticals$227.94+0.4%4.8293 of 5 stars2.92$393.86 72.8%24Analyst Forecast2.13%INSMInsmed$123.88-1.9%3.3513 of 5 stars3.00$205.52 65.9%26Insider TradeAnalyst Revision2.01%ASNDAscendis Pharma A/S$246.57+0.1%4.4995 of 5 stars3.06$299.24 21.4%18News CoverageEarnings ReportAnalyst Forecast2.01%UNHUnitedHealth Group$402.62+0.9%4.9377 of 5 stars2.89$455.92 13.2%27Dividend Announcement1.89%MRNAModerna$63.59-0.1%1.3524 of 5 stars1.88$42.13 -33.7%171.88%HTFLHeartflow$42.84+38.1%1.8679 of 5 stars2.75$43.43 1.4%12Trending NewsEarnings ReportAnalyst ForecastInsider TradeGap UpHigh Trading Volume1.87%EWEdwards Lifesciences$92.16-0.4%4.0741 of 5 stars2.74$100.27 8.8%23Positive News1.86%KNSAKiniksa Pharmaceuticals International$76.09-2.2%4.2157 of 5 stars2.90$87.38 14.8%10Positive News1.84%PCVXVaxcyte$58.27-1.0%2.2371 of 5 stars2.50$86.00 47.6%8Positive NewsAnalyst Upgrade1.69%GHGuardant Health$157.40-1.3%3.2473 of 5 stars2.96$183.78 16.8%25Insider Trade1.51%LEGNLegend Biotech$20.24-0.2%3.0824 of 5 stars2.47$52.29 158.4%15News CoverageEarnings ReportAnalyst Forecast This page (NASDAQ:FMED) was last updated on 8/14/2026 by MarketBeat.com Staff. From Our PartnersHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredTrump’s New Currency ResetTrump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...Porter & Company | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredSpaceX pays a 10X launch penaltySpaceX burns roughly $200,000 in fuel per Falcon 9 launch - about $20 million across 100 missions. One unde...Freedom Financial | SponsoredRay Dalio: Buy Gold. Get Paid.Ray Dalio, founder of Bridgewater Associates, is urging investors to hold 15% of their portfolio in gold and c...Investors Alley | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredWall Street is staring at the wrong AI tradeAnthropic just signed a 9.1 billion dollar, 20 year data center agreement covering 191 megawatts of capacity, ...The Oxford Club | SponsoredWhy I'm sending this one to my own familyBehind the Markets editor Kelly Maguire says she has never sent an email quite like this one. A sealed congres...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fidelity Disruptive Medicine ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Fidelity Disruptive Medicine ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
